Drug development and nanomedicine


Tatiana Bronich, Ph.D., develops bullets that carry drugs to hit precise targets.

The targets - disease sites in the body that, up until now, have been hard to reach.

Dr. Bronich, associate director of the Center for Drug Delivery and Nanomedicine and professor of pharmaceutical sciences, directs the Nanomaterials Core at UNMC where the microscopic drug delivery systems are customized to treat stroke, hypertension, traumatic brain injury, obesity, Parkinson's disease and cancer.

The Nanomaterials Core supports eight COBRE (Centers of Biomedical Research Excellence) project leaders in the development of nanoscale polymer materials -- particles 100,000 times smaller than the head of a pin -- for drug delivery, their characterization and safety evaluation.

 Tatiana Bronich, Ph.D.

Dr. Bronich and her team use state-of-the art equipment to produce materials for biomedical research and develop new technologies not yet employed in research. Core researchers develop nanozymes as a platform technology for delivery of antioxidants and antiviral drugs to targeted sites.

Read about the goals for the Nanomaterials Core.


Life-saving drug
Jonathan Vennerstrom, Ph.D.
Researcher combines past with passion

A powerful new drug will help take the bite out of malaria.

From Coins to Cancer
Novel compounds lead to powerful new treatments for cancer and other diseases. in this article, learn more about a researcher's curiosity and how it can improve drug treatments.